Cargando…
Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
BACKGROUND: In an early study of highly symptomatic patients with PI*Z alpha-1 antitrypsin deficiency (AAT), tobacco smoking was identified as a risk factor by comparing the age of symptom onset in smokers and nonsmokers. Age of symptom onset has not been well studied in relationship to other enviro...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707814/ https://www.ncbi.nlm.nih.gov/pubmed/18044105 |
_version_ | 1782169188239933440 |
---|---|
author | Mayer, Annyce S Stoller, James K Vedal, Sverre Ruttenber, A James Strand, Matt Sandhaus, Robert A Newman, Lee S |
author_facet | Mayer, Annyce S Stoller, James K Vedal, Sverre Ruttenber, A James Strand, Matt Sandhaus, Robert A Newman, Lee S |
author_sort | Mayer, Annyce S |
collection | PubMed |
description | BACKGROUND: In an early study of highly symptomatic patients with PI*Z alpha-1 antitrypsin deficiency (AAT), tobacco smoking was identified as a risk factor by comparing the age of symptom onset in smokers and nonsmokers. Age of symptom onset has not been well studied in relationship to other environmental exposures. METHODS: Environmental exposures were assessed in 313 PI*Z adults through retrospective self-administered questionnaire. Age of onset of symptoms with and without these exposures were analyzed through survival analysis. RESULTS: Personal smoking was the most important risk factor, associated with earlier onset of cough and wheeze, and showed a dose-dependent relationship with the onset of dyspnea. Childhood environmental tobacco smoke (ETS) exposure was independently associated with younger age of onset of cough. Earlier onset of wheeze was also associated with childhood respiratory infections and family history of emphysema. The report of childhood respiratory infections was associated with childhood ETS exposure, but no statistically significant interactions were noted. CONCLUSIONS: We conclude that both personal and secondhand exposure to tobacco smoke in childhood are likely to accelerate the onset of symptoms in AAT deficient patients. Respiratory infections in childhood may also contribute to this risk. |
format | Text |
id | pubmed-2707814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27078142009-07-27 Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency Mayer, Annyce S Stoller, James K Vedal, Sverre Ruttenber, A James Strand, Matt Sandhaus, Robert A Newman, Lee S Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: In an early study of highly symptomatic patients with PI*Z alpha-1 antitrypsin deficiency (AAT), tobacco smoking was identified as a risk factor by comparing the age of symptom onset in smokers and nonsmokers. Age of symptom onset has not been well studied in relationship to other environmental exposures. METHODS: Environmental exposures were assessed in 313 PI*Z adults through retrospective self-administered questionnaire. Age of onset of symptoms with and without these exposures were analyzed through survival analysis. RESULTS: Personal smoking was the most important risk factor, associated with earlier onset of cough and wheeze, and showed a dose-dependent relationship with the onset of dyspnea. Childhood environmental tobacco smoke (ETS) exposure was independently associated with younger age of onset of cough. Earlier onset of wheeze was also associated with childhood respiratory infections and family history of emphysema. The report of childhood respiratory infections was associated with childhood ETS exposure, but no statistically significant interactions were noted. CONCLUSIONS: We conclude that both personal and secondhand exposure to tobacco smoke in childhood are likely to accelerate the onset of symptoms in AAT deficient patients. Respiratory infections in childhood may also contribute to this risk. Dove Medical Press 2006-12 2006-12 /pmc/articles/PMC2707814/ /pubmed/18044105 Text en © 2006 Dove Medical Press Limited. All rights reserved |
spellingShingle | Original Research Mayer, Annyce S Stoller, James K Vedal, Sverre Ruttenber, A James Strand, Matt Sandhaus, Robert A Newman, Lee S Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency |
title | Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency |
title_full | Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency |
title_fullStr | Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency |
title_full_unstemmed | Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency |
title_short | Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency |
title_sort | risk factors for symptom onset in pi*z alpha-1 antitrypsin deficiency |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707814/ https://www.ncbi.nlm.nih.gov/pubmed/18044105 |
work_keys_str_mv | AT mayerannyces riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency AT stollerjamesk riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency AT vedalsverre riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency AT ruttenberajames riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency AT strandmatt riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency AT sandhausroberta riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency AT newmanlees riskfactorsforsymptomonsetinpizalpha1antitrypsindeficiency |